NEW YORK (GenomeWeb) - Nanosphere today announced after the close of the market that its third quarter revenues rose 33 percent on sales of its Verigene Gram Positive and Gram Negative Blood Culture Tests.

For the three months ended Sept. 30, the Northbrook, Illinois-based molecular diagnostics company said it posted record-high revenues of $4.9 million, up from $3.7 million a year ago, and in line with the average Wall Street expectation.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.